
CHOP Researchers Unveil Nanoparticle Platform for Cancer Immunotherapy
Researchers at the Children's Hospital of Philadelphia have developed a nanoparticle-based platform capable of mimicking diseased cell surfaces to accelerate cancer immunotherapy. By presenting cancer-associated protein fragments on a virus-like structure, the system allows for the rapid, high-throughput screening of T cell responses against specific tumor targets.

























